BioCryst Pharmaceuticals | BCRX - EPS Earnings Per Share


BioCryst Pharmaceuticals reported $1.17 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Chugai Pharma JPY 70.13 7.9 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
DBV Technologies USD -0.24 1.31 Sep/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD -0.03 1.64 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026